Olix Pharmaceuticals, Inc.

Clinical trials sponsored by Olix Pharmaceuticals, Inc., explained in plain language.

Olix Pharmaceuticals, Inc. 226950 KOSDAQ

Biopharmaceutical company developing RNAi therapeutics for skin and eye diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1 Completed 1

New scalp injection could regrow hair in balding men

Disease control Recruiting now

This study tests an experimental drug called OLX72021 in 158 men with mild to moderate male pattern baldness. The drug is injected into the scalp at different doses to see if it is safe and can increase hair count compared to a placebo. The trial is currently recruiting participa…

Phase 1/2 • Sponsor: Olix Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

Olix Pharmaceuticals, Inc.

New scalp injection could regrow hair in balding men